Saroja Pharma Industries India Limited (NSE:SAROJA)

NSE:SAROJA Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	3.39	3.32	3.22	3.64	2.65
Cash & Short-Term Investments	3.39	3.32	3.22	3.64	2.65
Cash Growth	1.99%	3.20%	-11.62%	37.60%	6353.66%
Accounts Receivable	173.03	265.78	162.4	111.08	139.8
Other Receivables	-	1.38	5.74	5.52	0.76
Receivables	173.03	267.17	168.14	116.59	140.56
Inventory	8.6	0.99	3.98	38.66	4.67
Prepaid Expenses	-	0.21	0.19	0.35	0.48
Other Current Assets	0.57	0.48	0.45	2.25	2.57
Total Current Assets	185.59	272.16	175.98	161.49	150.92
Property, Plant & Equipment	225.17	111.19	86.39	40.03	3.42
Long-Term Investments	5.41	3.41	1.99	1.42	0.39
Other Intangible Assets	-	-	-	0.01	0.03
Other Long-Term Assets	1.3	8.76	1.27	10.45	0.37
Total Assets	417.47	395.53	265.62	213.4	155.12

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	84.65	136.49	56.09	58.63	53.05
Accrued Expenses	-	0.1	0.23	0.17	0.24
Short-Term Debt	70.54	80.75	31.14	73.77	44.42
Current Income Taxes Payable	-	0.81	0.04	1.72	-
Other Current Liabilities	15.73	6.74	5.42	-	0.14
Total Current Liabilities	170.92	224.9	92.92	134.29	97.85
Long-Term Debt	73.61	13.81	26.21	28.12	16.97
Long-Term Deferred Tax Liabilities	0.04	0.07	0.09	0.13	0.03
Other Long-Term Liabilities	-	0	-	-	-
Total Liabilities	244.57	238.77	119.21	162.53	114.86

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	40.21	40.21	40.21	29.36	2.26
Additional Paid-In Capital	-	75.92	75.92	-	17.34
Retained Earnings	132.7	40.63	30.29	21.51	20.66
Shareholders' Equity	172.9	156.76	146.42	50.87	40.26
Total Liabilities & Equity	417.47	395.53	265.62	213.4	155.12

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	144.15	94.56	57.35	101.89	61.39
Net Cash (Debt)	-140.76	-91.24	-54.13	-98.25	-58.74
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-34.97	-22.69	-15.33	-33.44	-20.43
Filing Date Shares Outstanding	4.04	4.02	4.02	2.94	2.94
Total Common Shares Outstanding	4.04	4.02	4.02	2.94	2.94
Working Capital	14.67	47.27	83.06	27.2	53.06
Book Value Per Share	42.83	38.99	36.42	17.33	13.71
Tangible Book Value	172.9	156.76	146.42	50.85	40.23
Tangible Book Value Per Share	42.83	38.99	36.42	17.32	13.71
Land	-	18.97	18.97	18.97	-
Machinery	-	9.5	8.42	4.5	4.09
Construction In Progress	-	86.13	61.27	17.89	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 5, 2026

Data Sources Report a data error